Table 3 |
||||
|
CMR results in acute myocarditis and at follw-up |
||||
| Variable |
Acute |
Follow-up |
Difference between means |
P-value acute vs. follow-up |
|
|
||||
| LV mass (g) |
156.66 ± 30.56 |
140.33 ± 28.30 |
-16.33 |
<0.0001 |
| LV mass/height (g/cm) |
0.90 ± 0.15 |
0.80 ± 0.12 |
-0.10 |
0.0001 |
| LVEDV (ml) |
158.10 ± 40.01 |
153.57 ± 37.50 |
-4.52 |
0.395 |
| LVEDV/height (ml/cm) |
0.89 ± 0.19 |
0.85 ± 0.19 |
-0.04 |
0.2859 |
| Ejection fraction (%) |
59.95 ± 6.39 |
64.14 ± 5.26 |
4.19 |
0.015 |
| T2 ratio |
2.41 ± 0.39 |
1.68 ± 0.29 |
-0.72 |
<0.0001 |
|
Quantitative results of CMR in the acute and convalescent phase (follow-up) of myocarditis (mean ± SD): LV mass, LV mass/height, LVEDV, LVEDV/height, ejection fraction, T2 ratio | ||||
Zagrosek et al. Journal of Cardiovascular Magnetic Resonance 2008 10:19 doi:10.1186/1532-429X-10-19 |
||||
